Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-10-09

FDA Approved: LACOSAMIDE — Original Application (Somerset Therapeutics, LLC)

View source ↗

Summary

FDA approved the original application for lacosamide by Somerset Therapeutics, LLC, approving a generic version of the anticonvulsant.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lacosamide (Lacosamide)

Snippet

ORIG AP for LACOSAMIDE (LACOSAMIDE)